Skip to main content
SpringerLink
Log in

Continuous infusion of 1,25-dihydroxyvitamin D3 stimulates bone turnover in the normal young mouse

  • Laboratory Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

The effects of continuous administration of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] on mineral and bone metabolism have been examined in the normal mouse. Four doses (0.05–0.25µg/kg/day) of 1,25(OH)2D3 were infused continuously for 4 weeks in 21-day-old intact animals. Mineral and skeletal changes were evaluated by analytical methods and by histomorphometric analysis of endosteal bone formation and resorption parameters. All doses of 1,25(OH)2D3 increased the fractional osteoclastic surface and the osteoclast number in conjunction with increased hydroxyproline excretion. 1,25(OH)2D3 induced a dose-dependent elevation of the calcification rate, reduction of the mean osteoid seam thickness, and shortening of the mineralization lag time. In addition, there was a dose-related increase in the extent of tetracycline double-labeled osteoid surface and a concurrent rise in the fractional osteoblastic surface associated with elevated serum alkaline phosphatase levels. Increased bone formation appeared to have been balanced by increased bone resorption since the trabecular bone volume remained unchanged.

Except at the highest dose given, serum calcium and phosphate concentrations remained normal in spite of increased bone mobilization and presumably enhanced intestinal absorption of minerals. Urinary cAMP and TmP/GFR remained normal, suggesting that parathormone secretion was not altered.

The results show that continuous 1,25(OH)2D3 infusion in the young mouse produces a dose-dependent stimulation of bone mineralization rate in response to increased osteoclastic bone resorption. The data indicate that 1,25(OH)2D3 can regulate bone turnover as well as mineral homeostasis in the young mouse.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Raisz LG (1980) Direct effects of vitamin D and its metabolites on skeletal tissue. Clin Endocrinol Metab 9:27–41

    Article  CAS  PubMed  Google Scholar 

  2. Weisbrode SE, Capen CC, Norman AW (1978) Ultrastructural evaluation of the effects of 1,25-dihydroxyvitamin D3 on bone of thyroparathyroidectomised rats fed a low calcium diet. Am J Pathol 92:459–472

    CAS  PubMed  Google Scholar 

  3. Queillé ML, Miravet L, Bordier P, Redel J (1978) The action of vitamin D metabolites (25 OHD3 - 1,25(OH)2D3 - 24,25(OH)2D3- 25,26(OH)2D3) on vitamin D deficient rats. Biomedicine 28:237–242

    PubMed  Google Scholar 

  4. Holtrop ME, Cox KA, Clark MB, Holick MF, Anast CS (1981) 1,25-dihydroxycholecalciferol stimulates osteoclasts in rat bones in the absence of parathyroid hormone. Endocrinology 108:2293–2301

    CAS  PubMed  Google Scholar 

  5. Raisz LG, Maina DM, Gworek SG, Dietrich JW, Canalis EM (1978) Hormonal control of bone collagen synthesis in vitro—inhibitory effect of 1-hydroxylated vitamin D metabolites. Endocrinology 102:731–735

    Article  CAS  PubMed  Google Scholar 

  6. Wong GL, Luben RA, Cohn DV (1977) 1,25-Dihydroxycholecalciferol and parathormone: effects on isolated osteoclast-like and osteoblast-like cells. Science 197:663–667

    CAS  PubMed  Google Scholar 

  7. DeLuca HF, Schnoes HK (1976) Metabolism and mechanism of action of vitamin D. Annu Rev Biochem 45:631–666

    Article  CAS  PubMed  Google Scholar 

  8. Kugai N, Koide Y, Kimura S, Yamashita K, Ogata E (1981) Evidence for acute inhibitory effects in vivo of 1α-hydroxycholecalciferol on parathyroid hormone secretion in rats. Endocrinology 109:1078–1083

    CAS  PubMed  Google Scholar 

  9. Kream BE, Jose M, Yamada S, DeLuca HF (1977) A specific high-affinity binding macromolecule for 1,25 dihydroxyvitamin D3 in fetal bone. Science 197:1086–1088

    CAS  PubMed  Google Scholar 

  10. Manolagas SC, Taylor CM, Anderson DC (1979) Highly specific binding of 1,25 dihydroxycholecalciferol in bone cytosol. J Endocrinol 80:35–40

    Article  CAS  PubMed  Google Scholar 

  11. Holtrop ME, Raisz LG (1979) Comparison of the effects of 1,25-dihydroxycholecalciferol, prostaglandin E2 and osteoclast-activating factor with parathyroid hormone on the ultrastructure of osteoclasts in cultured long bones of fetal rats. Calcif Tissue Int 29:201–205

    CAS  PubMed  Google Scholar 

  12. Meunier PJ, Edouard C, Arlot M, Lejeune E, Alexandre C, Leroy G (1979) Effects of 1,25 dihydroxyvitamin D on bone mineralization. In: MacIntyre I, Szelke M (eds) Molecular endocrinology Elsevier/North Holland Biochemical Press, Amsterdam, pp 283–292

    Google Scholar 

  13. Mason RS, Lissner D, Posen S, Norman AW (1980) Blood concentrations of dihydroxylated vitamin D metabolites after an oral dose. Br Med J 1:449–451

    Article  Google Scholar 

  14. Marie PJ, Travers R, Glorieux FH (1981) Healing of bone lesions with 1,25 dihydroxycholecalciferol in the young X-linked hypophosphatemic mouse. In: Cohn DV, Talmage RV, Matthews JL (eds): Hormonal control of calcium metabolism. Excerpta Medica, Amsterdam, Oxford, Princeton, p 261

    Google Scholar 

  15. Walton RJ, Bijvoet OLM (1975) Nomogram for derivation of renal threshold phosphate concentration. Lancet 2:309–310

    Article  CAS  PubMed  Google Scholar 

  16. Ramamurthy NS, Zebrowski EJ, Golub LM (1971) A modified procedure for determining hydroxyproline in normal and diabetic urine. Biochem Med 5:555–558

    Article  CAS  Google Scholar 

  17. Marie PJ, Travers R, Glorieux FH (1981) Healing of rickets with phosphate supplementation in the hypophosphatemic male mouse. J Clin Invest 67:911–914

    CAS  PubMed  Google Scholar 

  18. Marie PJ, Travers R, Glorieux FH (1982) Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse. Calcif Tissue Int 34:158–164

    CAS  PubMed  Google Scholar 

  19. Frost HM (1977) A method of analysis of trabecular bone dynamics. In: Meunier PJ (ed) Bone histomorphometry. Armour Montagu, Paris, pp 445–476

    Google Scholar 

  20. Baylink D, Stauffer M, Wergedal J, Rich C (1970) Formation, mineralization and resorption of bone in vitamin D deficient rats. J Clin Invest 49:1122–1134

    Article  CAS  PubMed  Google Scholar 

  21. Dunnett CW (1955) A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 50:1096–1121

    Article  Google Scholar 

  22. Levine BS, Brautbar N, Welling MW, Lee DBN, Coburn JW (1980) Effects of vitamin D and diet magnesium on magnesium metabolism. Am J Physiol (Endocrinol Metab) 2:E515-E523

    Google Scholar 

  23. Tenenhouse HS, Scriver CR (1981) Effect of 1,25 dihydroxyvitamin D3 on phosphate homeostasis in the X-linked hypophosphatemic (Hyp) mouse. Endocrinology 109:658–660

    CAS  PubMed  Google Scholar 

  24. Gebauer U, Fleisch H (1978) Effect of 1,25 dihydroxycholecalciferol on adenosine 3′,5′-cyclic monophosphate production in calvaria of mice. Calcif Tissue Res 25:223–225

    Article  CAS  PubMed  Google Scholar 

  25. Marie PJ, Glorieux FH (1981) Stimulation of cortical bone mineralization and remodelling by phosphate and 1,25 dihydroxyvitamin D3 in vitamin D resistant rickets. Metab Bone Dis Rel Res 3:159–164

    Article  CAS  Google Scholar 

  26. Manolagas SC, Burton DW, Deftos LJ (1981) 1,25-Dihydroxyvitamin D3 stimulates the alkaline phosphatase activity of osteoblast-like cells. J Biol Chem 256:7115–7117

    CAS  PubMed  Google Scholar 

  27. Garabedian M, Pezant E, Miravet L, Fellot C, Balsan S (1976) 1,25 Dihydroxycholecalciferol effect on serum phosphorus homeostasis in rats. Endocrinology 98:794–799

    CAS  PubMed  Google Scholar 

  28. Parfitt AM (1976) The actions of parathyroid hormone on bone: relation to bone remodelling and turnover, calcium homeostasis and metabolic bone disease. Part I: Mechanisms of calcium transfer between blood and bone and their cellular basis: Morphologic and kinetic approaches to bone turnover. Metabolism 25:809–844

    Article  CAS  PubMed  Google Scholar 

  29. Frost HM (1973) Bone remodelling and its relation to metabolic bone disease. Charles C. Thomas, Springfield, Ill.

    Google Scholar 

  30. Howard GA, Bottemiller BL, Baylink DJ (1980) Evidence for the coupling of bone formation to bone resorption in vitro. Metab Bone Dis Rel Res 2:131–135

    Article  Google Scholar 

  31. Howard GA, Drivdahl RH, Baylink DJ (1980) Evidence of production and partial characterization of a coupling factor in bone metabolism. Calcif Tissue Int 31:53 (abst)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Genetics Unit, Montreal Shriners Hospital and the Department of Surgery, McGill University, H3G 1A6, Montreal, Quebec, Canada

    Pierre J. Marie & Rose Travers

Authors
  1. Pierre J. Marie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rose Travers
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marie, P.J., Travers, R. Continuous infusion of 1,25-dihydroxyvitamin D3 stimulates bone turnover in the normal young mouse. Calcif Tissue Int 35, 418–425 (1983). https://doi.org/10.1007/BF02405070

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02405070

Key words

Search

Navigation